CNS Pharmaceuticals, Inc. (CNSP) › Weighted Average Diluted SharesCNS Pharmaceuticals, Inc. (CNSP) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-12-31: 878.4K2022-12-31: 1.36M2023-12-31: 1.5K2024-12-31: 31.8K2025-12-31: 443.4K443.4K2021-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31443.4K+1293.2%2026-03-31From 2025-01-012024-12-3131.8K+2011.7%2026-03-31From 2024-01-012023-12-311.5K-99.9%2025-03-31From 2023-01-012022-12-311.36M+55.0%2024-04-01From 2022-01-012021-12-31878.4K—2023-03-31From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)